A Closer Look at 5 Analyst Recommendations For Patterson Cos
Portfolio Pulse from Benzinga Insights
Patterson Cos (NASDAQ:PDCO) has been analyzed by 5 analysts, showing a mix of somewhat bullish and indifferent ratings. The average 12-month price target is now $33.00, down from $36.75, indicating a 10.2% decrease. Analysts from Leerink Partners, Goldman Sachs, Piper Sandler, and Morgan Stanley have adjusted their ratings and price targets, reflecting changes in market dynamics and company performance. Patterson Cos, a leading dental and animal health distributor, shows strong financial health with notable revenue growth, net margin, ROE, and ROA, despite a lower market capitalization compared to industry peers.
February 26, 2024 | 2:00 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Patterson Cos has received mixed analyst ratings with a downward revision in the average price target to $33.00, indicating a potential short-term negative impact on its stock price.
The downward revision in the average price target by analysts from reputable firms such as Leerink Partners, Goldman Sachs, Piper Sandler, and Morgan Stanley suggests a bearish outlook on Patterson Cos's stock in the short term. This, combined with the diverse range of ratings from bullish to indifferent, indicates uncertainty and potential volatility in the stock's performance. The decrease in the average price target reflects analysts' adjusted expectations based on recent market dynamics and company performance, likely influencing investor sentiment and stock price movement.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100